Pick Topic
Review Topic
List Experts
Examine Expert
Save Expert
  Site Guide ··   
Expertise in Melanoma: HELP
Lydia Gaba
Based on 7 articles published since 2009
(Why 7 articles?)
||||
Expertise Level
The expertise of Lydia Gaba ranks in the
  • Top 8%
  • ... of 106,334 published authors worldwide on Melanoma
  • ... from 2009 through 2019
  • ... based on contributions to 7 articles on the topic.
Graphical view (beta)
Aliases Gaba, L   ·   Gaba, Lydia
Work Locations
Details
Most likely:    Universitat de Barcelona      
2018
  • The Christie NHS Foundation Trust, and University of Manchester, Manchester, UK; CRUK Manchester Institute, Manchester, UK. · Melanoma Institute Australia and the University of Sydney, Sydney, NSW, Australia; Westmead and Blacktown Hospitals, Westmead, Australia. · University Hospital of Zurich, Zurich, Switzerland. · Massachusetts General Hospital, Cancer Center, Boston, MA, USA. · Peter MacCallum Cancer Centre and University of Melbourne, Melbourne, Australia. · University Hospital Essen, Essen and German Cancer Consortium, Germany. · Schleswig-Holstein University Hospital, Kiel, Germany. · Melanoma Institute Australia and the University of Sydney, Sydney, NSW, Australia; Royal North Shore and Mater Hospitals, Australia. · Hospital Clínic de Barcelona, Barcelona, Spain. · Istituto Nazionale Tumori "Fondazione G. Pascale"-IRCCS, Naples, Italy. · Medical Oncology and Immunotherapy University Hospital of Siena, Siena, Italy. · IRCCS - IRST (Istituto Scientifico Romagnolo per Lo Studio e La Cura Dei Tumori), Meldola, Italy. · The Royal Marsden NHS Foundation Trust, London, UK. · Melanoma Institute Australia and the University of Sydney, Sydney, NSW, Australia. · The Christie NHS Foundation Trust, and University of Manchester, Manchester, UK. Electronic address: · Pubmed 29360604
2017
  • Translational Genomics and Targeted Therapeutics in Solid Tumors, August Pi i Sunyer Biomedical Research Institute (IDIBAPS), Barcelona, Spain. · Medical Oncology Department, Hospital Clínic of Barcelona, Barcelona, Spain. · Translational Genomics Group, Vall d'Hebron Institute of Oncology (VHIO), Barcelona, Spain. · Medical Oncology Department, Vall d'Hebron Hospital, Barcelona, Spain. · Translational Genomics and Targeted Therapeutics in Solid Tumors, August Pi i Sunyer Biomedical Research Institute (IDIBAPS), Barcelona, Spain. · Molecular Oncology Group, Vall d'Hebron Institute of Oncology (VHIO), Barcelona, Spain. · Pathology Department, Hospital Clínic of Barcelona, Barcelona, Spain. · Department of Bioinformatics, Lineberger Comprehensive Cancer Center, Chapel Hill, North Carolina. · Cancer Genomics Group, Vall d'Hebron Institute of Oncology (VHIO), Barcelona, Spain. · Pubmed 28487385
  • Department of Neurology, Hospital Clínic, University of Barcelona, Barcelona, Spain. · Neuroimmunology Program, Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Barcelona, Spain. · Medical Oncology Department, Hospital Clínic, University of Barcelona, Barcelona, Spain. · Pubmed 28439919
  • Department of Medical Oncology, Hospital Clínic, Barcelona, Spain. · Translational Genomics and Targeted Therapeutics in Solid Tumors, Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Barcelona, Spain. · Department of Medical Oncology, Hospital Clínic, Barcelona, Spain. · Translational Genomics and Targeted Therapeutics in Solid Tumors, Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Barcelona, Spain. · Pubmed 27147251
2016
  • Medical Oncology Department, Hospital Clinic Barcelona, Villaroel 170, 08036 Barcelona, Spain. · Targeted Therapeutics & Translational Genomics in Solid Tumors, Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS) Barcelona, Spain. · Pubmed 27581765
  • Medical Oncology Department, Hospital Clinic Barcelona, Barcelona, Spain. · Translational Genomics & Targeted Therapeutics in Solid Tumors, Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Barcelona, Spain. · Dermatology Department, Hospital Clinic Barcelona, Barcelona, Spain. · CIBER Enfermedades Raras, Instituto de Salud Carlos III, Spain, Madrid, Spain. · University of Barcelona, Barcelona, Spain. · Pubmed 27115320
2017
  • Dermatology Department, Melanoma Unit, Hospital Clinic and IDIBAPS (Institut d'Investigacions Biomèdiques August Pi i Sunyer, Barcelona, Spain. · Pubmed 27353949
Specific Interests

In the titles of their published articles, experts often reveal their very specific interests.

Here are the titles of all articles written by Lydia Gaba in 2009-2019 about Melanoma:

  • Rechallenge with BRAF-directed treatment in metastatic melanoma: A multi-institutional retrospective study. 2018
  • Immune-Related Gene Expression Profiling After PD-1 Blockade in Non-Small Cell Lung Carcinoma, Head and Neck Squamous Cell Carcinoma, and Melanoma. 2017
  • Motor polyradiculopathy during pembrolizumab treatment of metastatic melanoma. 2017
  • Development of Cutaneous Toxicities During Selective Anti-BRAF Therapies: Preventive Role of Combination with MEK Inhibitors. 2017
  • Sequential treatment with immunotherapy and BRAF inhibitors in BRAF-mutant advanced melanoma. 2017
  • Ipilimumab after progression on anti-PD-1 treatment in advanced melanoma. 2016
  • Pembrolizumab in a BRAF-mutant metastatic melanoma patient following a severe immune-related adverse event with ipilimumab. 2016
Show List of Full Article Records
Google Searches

Learn more about Lydia Gaba using the ready-made Google searches below.
This is essential! -- Publications never tell the whole story!

General Search:
Universitat de Barcelona
Affiliation Timeline
Click for institutional directory in table below. (Not always available.)
What is this?
Universitat de Barcelona
2018
  • The Christie NHS Foundation Trust, and University of Manchester, Manchester, UK; CRUK Manchester Institute, Manchester, UK. · Melanoma Institute Australia and the University of Sydney, Sydney, NSW, Australia; Westmead and Blacktown Hospitals, Westmead, Australia. · University Hospital of Zurich, Zurich, Switzerland. · Massachusetts General Hospital, Cancer Center, Boston, MA, USA. · Peter MacCallum Cancer Centre and University of Melbourne, Melbourne, Australia. · University Hospital Essen, Essen and German Cancer Consortium, Germany. · Schleswig-Holstein University Hospital, Kiel, Germany. · Melanoma Institute Australia and the University of Sydney, Sydney, NSW, Australia; Royal North Shore and Mater Hospitals, Australia. · Hospital Clínic de Barcelona, Barcelona, Spain. · Istituto Nazionale Tumori "Fondazione G. Pascale"-IRCCS, Naples, Italy. · Medical Oncology and Immunotherapy University Hospital of Siena, Siena, Italy. · IRCCS - IRST (Istituto Scientifico Romagnolo per Lo Studio e La Cura Dei Tumori), Meldola, Italy. · The Royal Marsden NHS Foundation Trust, London, UK. · Melanoma Institute Australia and the University of Sydney, Sydney, NSW, Australia. · The Christie NHS Foundation Trust, and University of Manchester, Manchester, UK. Electronic address: · Pubmed 29360604
2017
  • Translational Genomics and Targeted Therapeutics in Solid Tumors, August Pi i Sunyer Biomedical Research Institute (IDIBAPS), Barcelona, Spain. · Medical Oncology Department, Hospital Clínic of Barcelona, Barcelona, Spain. · Translational Genomics Group, Vall d'Hebron Institute of Oncology (VHIO), Barcelona, Spain. · Medical Oncology Department, Vall d'Hebron Hospital, Barcelona, Spain. · Translational Genomics and Targeted Therapeutics in Solid Tumors, August Pi i Sunyer Biomedical Research Institute (IDIBAPS), Barcelona, Spain. · Molecular Oncology Group, Vall d'Hebron Institute of Oncology (VHIO), Barcelona, Spain. · Pathology Department, Hospital Clínic of Barcelona, Barcelona, Spain. · Department of Bioinformatics, Lineberger Comprehensive Cancer Center, Chapel Hill, North Carolina. · Cancer Genomics Group, Vall d'Hebron Institute of Oncology (VHIO), Barcelona, Spain. · Pubmed 28487385
  • Department of Neurology, Hospital Clínic, University of Barcelona, Barcelona, Spain. · Neuroimmunology Program, Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Barcelona, Spain. · Medical Oncology Department, Hospital Clínic, University of Barcelona, Barcelona, Spain. · Pubmed 28439919
  • Department of Medical Oncology, Hospital Clínic, Barcelona, Spain. · Translational Genomics and Targeted Therapeutics in Solid Tumors, Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Barcelona, Spain. · Department of Medical Oncology, Hospital Clínic, Barcelona, Spain. · Translational Genomics and Targeted Therapeutics in Solid Tumors, Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Barcelona, Spain. · Pubmed 27147251
2016
  • Medical Oncology Department, Hospital Clinic Barcelona, Villaroel 170, 08036 Barcelona, Spain. · Targeted Therapeutics & Translational Genomics in Solid Tumors, Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS) Barcelona, Spain. · Pubmed 27581765
  • Medical Oncology Department, Hospital Clinic Barcelona, Barcelona, Spain. · Translational Genomics & Targeted Therapeutics in Solid Tumors, Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Barcelona, Spain. · Dermatology Department, Hospital Clinic Barcelona, Barcelona, Spain. · CIBER Enfermedades Raras, Instituto de Salud Carlos III, Spain, Madrid, Spain. · University of Barcelona, Barcelona, Spain. · Pubmed 27115320
2017
  • Dermatology Department, Melanoma Unit, Hospital Clinic and IDIBAPS (Institut d'Investigacions Biomèdiques August Pi i Sunyer, Barcelona, Spain. · Pubmed 27353949
Yearly article counts 01420000000
Remember this Person You can save this page -- like a bookmark -- so it's remembered for you on the Expertscape "Saved Pages" page, which is always easily available from the page-top menu bar throughout the site.